Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-38.6%
5Y CAGR+8.8%
Year-over-Year Change
Research and development spending
3Y CAGR
-38.6%/yr
Annual compound
5Y CAGR
+8.8%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $243.77M | -42.5% |
| 2024 | $424.06M | -27.0% |
| 2023 | $580.62M | -44.8% |
| 2022 | $1.05B | -8.4% |
| 2021 | $1.15B | +619.6% |
| 2020 | $159.77M | +65.9% |
| 2019 | $96.30M | - |